Skip to main content

Statistics Presented for Global Cancer Incidence, Deaths in 2022

Medically reviewed by Carmen Pope, BPharm. Last updated on April 4, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, April 4, 2024 -- In 2022, there were almost 20 million new cases of cancer as well as 9.7 million deaths from cancer, according to a study published online April 4 in CA: A Cancer Journal for Clinicians.

Freddie Bray, Ph.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues present global cancer statistics for 2022 by world region.

The researchers found there were about 20 million new cases of cancer in 2022, including nonmelanoma skin cancers, as well as 9.7 million deaths from cancer. These estimates suggest that about one in five men or women develop cancer in a lifetime, and one in nine men and one in 12 women die from cancer. In 2022, lung cancer was the most frequently diagnosed cancer, responsible for close to 2.5 million new cases (12.4 percent of cancers globally), followed by cancers of the female breast, colorectum, prostate, and stomach (11.6, 9.6, 7.3, and 4.9 percent, respectively). The leading cause of cancer death was lung cancer, with an estimated 1.8 million deaths (18.7 percent), followed by colorectal, liver, female breast, and stomach cancers (9.3, 7.8, 6.9, and 6.8 percent, respectively). In women and men, the most frequent cancers were breast and lung cancer (both cases and deaths). Across world regions, incidence rates varied from fourfold to fivefold for men and women.

"The overall scale of cancer and the diversity of cancer profiles by world region and human development level reemphasize the need for a global escalation of targeted cancer control measures," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Researchers Compare Race-Based, Race-Neutral Lung Function Equations

TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...

Survival Benefit for Cancer Trial Participants Does Not Persist in Adjusted Analyses

TUESDAY, May 21, 2024 -- In studies using designs addressing sources of bias and confounding, there is no evidence of a survival benefit for cancer trial participants, according...

Genital Talc Use Positively Linked to Ovarian Cancer

TUESDAY, May 21, 2024 -- There is a positive association between use of intimate care products, including genital talc, and ovarian cancer, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.